These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25155283)

  • 1. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer.
    Nakashima S; Kobayashi S; Sakai D; Tomokuni A; Tomimaru Y; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Matsuura N; Doki Y; Mori M; Nagano H
    J Surg Oncol; 2014 Dec; 110(8):1016-22. PubMed ID: 25155283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression on Prognosis After Surgical Resection for Biliary Carcinoma.
    Toyota K; Murakami Y; Kondo N; Uemura K; Nakagawa N; Takahashi S; Sueda T
    J Gastrointest Surg; 2017 Jun; 21(6):990-999. PubMed ID: 28342122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
    Takayama H; Kobayashi S; Gotoh K; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Asaoka T; Noda T; Wada H; Takahashi H; Tanemura M; Doki Y; Eguchi H
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10935-10950. PubMed ID: 37330435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells.
    Aghamaliyev U; Gaitantzi H; Thomas M; Simon-Keller K; Gaiser T; Marx A; Yagublu V; Araos J; Cai C; Valous NA; Halama N; Kiesslich T; Ebert M; Grützmann R; Rückert F; Breitkopf-Heinlein K
    Eur Surg Res; 2019; 60(1-2):1-12. PubMed ID: 30650425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of SPARC expression in pancreatic cancer progression and patient survival.
    Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
    Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
    Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
    Koukourakis MI; Giatromanolaki A; Brekken RA; Sivridis E; Gatter KC; Harris AL; Sage EH
    Cancer Res; 2003 Sep; 63(17):5376-80. PubMed ID: 14500371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of SPARC gene expression in patients with gastric cancer.
    Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
    J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC is associated with gastric cancer progression and poor survival of patients.
    Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
    Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of SPARC in clinical stage II tongue squamous cell carcinoma.
    Zhang J; Zhang Q; Zhang Q; Liu XK; Li CQ; Guo ZM
    Ai Zheng; 2009 Jan; 28(1):68-71. PubMed ID: 19448421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
    Shen LC; Chen YK; Hsue SS; Shaw SY
    J Oral Pathol Med; 2010 Mar; 39(3):242-9. PubMed ID: 20070483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.
    Byrling J; Sasor A; Nilsson J; Said Hilmersson K; Andersson R; Andersson B
    Scand J Gastroenterol; 2020 Jun; 55(6):725-731. PubMed ID: 32543919
    [No Abstract]   [Full Text] [Related]  

  • 15. Secreted protein acidic and rich in cysteine expression in human colorectal cancer predicts postoperative prognosis.
    Liu QZ; Gao XH; Chang WJ; Wang HT; Wang H; Cao GW; Fu CG
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1803-11. PubMed ID: 26044224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
    Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
    Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases.
    Kato Y; Nagashima Y; Baba Y; Kawano T; Furukawa M; Kubota A; Yanoma S; Imagawa-Ishiguro Y; Satake K; Taguchi T; Hata R; Mochimatsu I; Aoki I; Kameda Y; Inayama Y; Tsukuda M
    Int J Mol Med; 2005 Aug; 16(2):263-8. PubMed ID: 16012759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma.
    Hsiao YH; Lien HC; Hwa HL; Kuo WH; Chang KJ; Hsieh FJ
    Breast J; 2010; 16(3):305-8. PubMed ID: 20210803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer.
    Kawamata H; Yamashita K; Nakamura K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Kumamoto Y; Watanabe M
    Anticancer Res; 2013 Feb; 33(2):583-94. PubMed ID: 23393352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.